Lumexa Imaging (NASDAQ:LMRI) Trading Up 11.9% on Analyst Upgrade

Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI)’s share price shot up 11.9% during mid-day trading on Tuesday after Raymond James Financial upgraded the stock from an outperform rating to a strong-buy rating. Raymond James Financial now has a $23.00 price target on the stock. Lumexa Imaging traded as high as $12.98 and last traded at $12.93. 133,065 shares traded hands during trading, a decline of 79% from the average session volume of 629,993 shares. The stock had previously closed at $11.55.

Institutional Investors Weigh In On Lumexa Imaging

Several large investors have recently made changes to their positions in the company. Goldman Sachs Group Inc. purchased a new position in Lumexa Imaging during the 4th quarter valued at approximately $18,870,000. JPMorgan Chase & Co. bought a new position in shares of Lumexa Imaging during the 4th quarter valued at approximately $15,954,000. Geode Capital Management LLC purchased a new position in shares of Lumexa Imaging in the fourth quarter valued at $1,548,000. TD Asset Management Inc bought a new stake in Lumexa Imaging in the fourth quarter worth $1,264,000. Finally, Seven Grand Managers LLC purchased a new stake in Lumexa Imaging during the fourth quarter valued at $11,942,000.

Lumexa Imaging Price Performance

About Lumexa Imaging

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).